Tyrosine kinase inhibitor induced isolated pericardial effusion.

about

Bosutinib induced pleural effusions: Case report and review of tyrosine kinase inhibitors induced pulmonary toxicity.

P2860

Q39339523-39BF1DEC-9CC0-410C-9BAE-356EDA6F3F24

P2860

Tyrosine kinase inhibitor induced isolated pericardial effusion.

Item

http://www.wikidata.org/entity/Q41351543

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Tyrosine kinase inhibitor induced isolated pericardial effusion.

@en

type

Item

label

Tyrosine kinase inhibitor induced isolated pericardial effusion.

@en

prefLabel

Tyrosine kinase inhibitor induced isolated pericardial effusion.

@en

P1476

Tyrosine kinase inhibitor induced isolated pericardial effusion.

@en

P2093

Eric S Christenson

http://www.w3.org/2001/XMLSchema#string

Margaret M Showel

http://www.w3.org/2001/XMLSchema#string

Vineet Agrawal

http://www.w3.org/2001/XMLSchema#string

P2860

Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia

Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is effective in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in chronic phase following imatinib resistance and intolerance.

Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia.

Serosal inflammation (pleural and pericardial effusions) related to tyrosine kinase inhibitors.

Chronic myelogenous leukemia for primary care physicians.

Tyrosine kinase inhibitors: views of selectivity, sensitivity, and clinical performance.

Estimations of the increasing prevalence and plateau prevalence of chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy.

Pleural effusions in patients with chronic myeloid leukaemia treated with dasatinib may have an immune-mediated pathogenesis.

Trends in leukemia incidence and survival in the United States (1973-1998).

Management of pericardial effusion.

P304

88-93

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.1159/000375484

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

273487320

http://www.w3.org/2001/XMLSchema#string

P698

25848358

http://www.w3.org/2001/XMLSchema#string

P932

4361914

http://www.w3.org/2001/XMLSchema#string

Tyrosine kinase inhibitor induced isolated pericardial effusion.

about

P2860

P2860

Tyrosine kinase inhibitor induced isolated pericardial effusion.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932